{"transactions":[{"id":832724,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:22:02.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":2.8,"value":11200.0,"ownership":{"direct":true},"balance_after":302338,"source":{"system":"sec-edgar","filing":"0001087294-26-000037","document":"wk-form4_1774041719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000037/wk-form4_1774041719.xml","form_type":"4"}},{"id":832723,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:22:02.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":2.8,"value":5040.0,"ownership":{"direct":true},"balance_after":298338,"source":{"system":"sec-edgar","filing":"0001087294-26-000037","document":"wk-form4_1774041719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000037/wk-form4_1774041719.xml","form_type":"4"}},{"id":948114,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-31","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.91,"value":242.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296538,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948113,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-30","kind":"other","planned":true,"acquired":true,"shares":54,"price":3.94,"value":212.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296476,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948112,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-29","kind":"other","planned":true,"acquired":true,"shares":54,"price":4.01,"value":216.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296422,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948111,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-26","kind":"other","planned":true,"acquired":true,"shares":54,"price":4.21,"value":227.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296368,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948110,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-24","kind":"other","planned":true,"acquired":true,"shares":54,"price":4.26,"value":230.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296314,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948109,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-23","kind":"other","planned":true,"acquired":true,"shares":54,"price":4.13,"value":223.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296260,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948108,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-22","kind":"other","planned":true,"acquired":true,"shares":50,"price":4.32,"value":216.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296206,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948107,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-19","kind":"other","planned":true,"acquired":true,"shares":52,"price":4.19,"value":217.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296156,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948106,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-18","kind":"other","planned":true,"acquired":true,"shares":67,"price":4.19,"value":280.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296104,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948105,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-17","kind":"other","planned":true,"acquired":true,"shares":67,"price":3.65,"value":244.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296037,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948104,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-16","kind":"other","planned":true,"acquired":true,"shares":104,"price":3.27,"value":340.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295970,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948103,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-15","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.82,"value":293.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295866,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948102,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-12","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.5,"value":260.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295762,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948101,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-11","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.56,"value":266.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295658,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948100,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-10","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.6,"value":270.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295554,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948099,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-09","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.32,"value":241.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295450,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948098,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-08","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.4,"value":249.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295346,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948097,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-05","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.34,"value":290.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295242,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948096,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-04","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.27,"value":281.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295118,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948095,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-03","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.25,"value":279.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294994,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948094,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-02","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.24,"value":277.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294870,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948093,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-01","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.36,"value":292.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294746,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":985485,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-28","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.41,"value":298.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294622,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985484,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-26","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.17,"value":269.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294498,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985483,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-25","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.21,"value":274.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294374,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985482,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-24","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.1,"value":260.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294250,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985481,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-21","kind":"other","planned":true,"acquired":true,"shares":117,"price":1.96,"value":229.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294126,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985480,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-20","kind":"other","planned":true,"acquired":true,"shares":117,"price":1.99,"value":232.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294009,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985479,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-19","kind":"other","planned":true,"acquired":true,"shares":117,"price":2.01,"value":235.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":293892,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985478,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-18","kind":"other","planned":true,"acquired":true,"shares":117,"price":1.98,"value":231.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":293775,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985477,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-17","kind":"other","planned":true,"acquired":true,"shares":117,"price":2.17,"value":253.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":293658,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985476,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-14","kind":"other","planned":true,"acquired":true,"shares":110,"price":2.15,"value":236.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":293541,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985475,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-13","kind":"other","planned":true,"acquired":true,"shares":110,"price":2.17,"value":238.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":293431,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985474,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-12","kind":"other","planned":true,"acquired":true,"shares":110,"price":1.99,"value":218.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":293321,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985473,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-11","kind":"other","planned":true,"acquired":true,"shares":110,"price":2.06,"value":226.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":293211,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985472,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-10","kind":"other","planned":true,"acquired":true,"shares":110,"price":2.11,"value":232.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":293101,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985471,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-07","kind":"other","planned":true,"acquired":true,"shares":96,"price":2.19,"value":210.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292991,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985470,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-06","kind":"other","planned":true,"acquired":true,"shares":96,"price":2.27,"value":217.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292895,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985469,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-05","kind":"other","planned":true,"acquired":true,"shares":68,"price":2.53,"value":172.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292799,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985468,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-04","kind":"other","planned":true,"acquired":true,"shares":68,"price":2.82,"value":191.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292731,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":985467,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:02:46.000Z","date":"2025-11-03","kind":"other","planned":true,"acquired":true,"shares":68,"price":2.8,"value":190.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292663,"source":{"system":"sec-edgar","filing":"0001087294-25-000025","document":"wk-form4_1764626562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000025/wk-form4_1764626562.xml","form_type":"4"}},{"id":1009921,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-31","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.39,"value":230.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292595,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009920,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-30","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.29,"value":223.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292527,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009919,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-29","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.26,"value":221.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292459,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009918,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-28","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.28,"value":223.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292391,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009917,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-27","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.49,"value":237.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292323,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009916,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-24","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.51,"value":238.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292255,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009915,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-23","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.44,"value":233.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292187,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009914,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-22","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.62,"value":246.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292119,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009913,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-21","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.61,"value":245.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":292051,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009912,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-20","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.52,"value":239.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291983,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009911,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-17","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.48,"value":236.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291915,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009910,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-16","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.49,"value":237.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291847,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009909,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-15","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.37,"value":229.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291779,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009908,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-14","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.35,"value":227.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291711,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009907,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-13","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.54,"value":240.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291643,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009906,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-10","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.59,"value":244.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291575,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009905,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-09","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.56,"value":242.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291507,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009904,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-08","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.63,"value":246.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291439,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009903,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-07","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.19,"value":216.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291371,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009902,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-06","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.14,"value":213.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291303,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009901,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-03","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.25,"value":221.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291235,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009900,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-02","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.28,"value":223.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291167,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1009899,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:55:01.000Z","date":"2025-10-01","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.31,"value":225.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291099,"source":{"system":"sec-edgar","filing":"0001695580-25-000004","document":"wk-form4_1762174497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000169558025000004/wk-form4_1762174497.xml","form_type":"4"}},{"id":1025366,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-30","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.12,"value":212.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":291031,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025365,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-29","kind":"other","planned":true,"acquired":true,"shares":68,"price":3.14,"value":213.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290963,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025364,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-26","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.05,"value":189.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290895,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025363,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-25","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.1,"value":192.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290833,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025362,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-24","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.1,"value":192.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290771,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025361,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-23","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.21,"value":199.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290709,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025360,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-22","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.29,"value":203.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290647,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025359,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-19","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.34,"value":207.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290585,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025358,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-18","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.31,"value":205.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290523,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025357,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-17","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.38,"value":209.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290461,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025356,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-16","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.5,"value":217.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290399,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025355,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-15","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.5,"value":217.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290337,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025354,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-12","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.54,"value":219.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290275,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025353,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-11","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.41,"value":211.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290213,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025352,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-10","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.39,"value":210.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290151,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025351,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-09","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.43,"value":212.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290089,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025350,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-08","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.41,"value":211.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":290027,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025349,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-05","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.6,"value":223.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":289965,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025348,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-04","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.6,"value":223.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":289903,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025347,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-03","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.58,"value":221.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":289841,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1025346,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:01:08.000Z","date":"2025-09-02","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.54,"value":219.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":289779,"source":{"system":"sec-edgar","filing":"0001087294-25-000006","document":"wk-form4_1759521664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000006/wk-form4_1759521664.xml","form_type":"4"}},{"id":1042058,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-29","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.45,"value":234.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289717,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042057,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-28","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.47,"value":235.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289649,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042056,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-27","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.44,"value":233.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289581,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042055,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-26","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.39,"value":230.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289513,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042054,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-25","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.32,"value":225.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289445,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042053,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-22","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.32,"value":225.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289377,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042052,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-21","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.31,"value":225.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289309,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042051,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-20","kind":"purchase","planned":true,"acquired":true,"shares":12,"price":3.15,"value":37.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289241,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042050,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-19","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.23,"value":219.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289229,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042049,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-18","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.11,"value":211.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289161,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042048,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-15","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":3.02,"value":205.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289093,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042047,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-14","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":2.84,"value":193.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":289025,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}},{"id":1042046,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:32:38.000Z","date":"2025-08-13","kind":"purchase","planned":true,"acquired":true,"shares":68,"price":2.94,"value":199.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":288957,"source":{"system":"sec-edgar","filing":"0001628280-25-041983","document":"wk-form4_1757680354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041983/wk-form4_1757680354.xml","form_type":"4"}}],"next_cursor":"2025-09-12T12:32:38.000000Z,1042046"}